Thus, Cdk1 could also be a potential therapeutic target for the treatment of bone and joint diseases such as osteoarthritis and osteochondrodysplasias by modulating chondrocyte proliferation and differentiation. This evidence concerns the gene CDK1 and osteoarthritis.